Merger13 May 2026, 01:36 pm
Onesource Specialty Pharma Scraps Merger with Steriscience Entities
AI Summary
Onesource Specialty Pharma Ltd has decided not to pursue the composite scheme of arrangement and amalgamation (merger by absorption) with Steriscience Specialities Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, and Strides Pharma Services Private Limited in its current form. The decision was made by the Board of Directors after deliberation, citing the best interest of all stakeholders. The company plans to revisit the transaction after the successful delivery of the respective companies’ FY28 guidance.
Key Highlights
- Onesource Specialty Pharma will not proceed with the proposed merger.
- The decision was made by the Board of Directors.
- The company will revisit the transaction after FY28 guidance.
- The initial in-principle approval was received on February 26, 2026.